ergonovine has been researched along with isosorbide-5-mononitrate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distante, A; L'Abbate, A; Lombardi, M; Morales, MA; Moscarelli, E | 1 |
| Distante, A; L'Abbate, A; Lombardi, M; Morales, MA; Moscarelli, E; Sabino, F | 1 |
| Distante, A; L'Abbate, A; Lombardi, M; Michelassi, C; Morales, MA; Moscarelli, E | 1 |
2 trial(s) available for ergonovine and isosorbide-5-mononitrate
| Article | Year |
|---|---|
Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
Topics: Aged; Coronary Disease; Echocardiography; Electrocardiography; Ergonovine; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1985 |
Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Angina Pectoris, Variant; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Ergonovine; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Vasodilator Agents | 1993 |
1 other study(ies) available for ergonovine and isosorbide-5-mononitrate
| Article | Year |
|---|---|
Oral isosorbide 5-mononitrate can protect from myocardial ischemia induced by ergonovine test and by isometric effort. Preliminary results from an echocardiographic acute study in anginal patients.
Topics: Administration, Oral; Coronary Disease; Coronary Vasospasm; Echocardiography; Ergonovine; Humans; Isometric Contraction; Isosorbide Dinitrate | 1987 |